Allergy and inflammation: An immunological and therapeutic approach

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 7, Issue 2, 2013, Pages 135-150

  Shukla, Shyamji ^a   Shukla, Harshita ^a   Kumar, Suneel ^a   Aharwal, Ravindra P ^a   Gupta, Vaibhav K ^a   Sandhu, Sardul S ^a  

^a RANI DURGAVATI UNIVERSITY   (India)

Author keywords

Allergy; Antibodies; Hypersensitivity; IgE; Inflammation; Macrophage; Therapeutic

Indexed keywords

ACECLOFENAC; ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; AZELASTINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CELECOXIB; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DIPHENHYDRAMINE; DOXANTRAZOLE; FIROCOXIB; GLUCOCORTICOID; IBUPROFEN; INDOMETACIN; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLXANTHINE DERIVATIVE; MONTELUKAST; NABUMETONE; NAPROXEN; NIMESULIDE; PENICILLIN DERIVATIVE; PIROXICAM; QUERCETIN; THEOPHYLLINE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNINDEXED DRUG;

ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ALLERGIC RHINITIS; ALLERGY; APNEA; ARTHRALGIA; ASTHMA; BASOPHIL; BRONCHOSPASM; CHRONIC FATIGUE SYNDROME; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PROSTATITIS; COMMON COLD; CYTOKINE PRODUCTION; DEHYDRATION; DROWSINESS; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG STRUCTURE; ECZEMA; EXERCISE INDUCED ASTHMA; EXTRAPYRAMIDAL SYMPTOM; FOOD ALLERGY; GOUT; HISTAMINE RELEASE; HOUSE DUST ALLERGY; HUMAN; HYPERTENSION; INFLAMMATION; INSOMNIA; MACROPHAGE; MAST CELL; MOTION SICKNESS; NASAL PRURITUS; NEOPLASM; NONHUMAN; NOSE OBSTRUCTION; PASSIVE SKIN ANAPHYLAXIS; PATENT; PENICILLIN ALLERGY; POLLEN ALLERGY; PRIORITY JOURNAL; PRURITUS; REVIEW; RHINORRHEA; SKIN ALLERGY; SWELLING; T LYMPHOCYTE ACTIVATION; URTICARIA; VIRUS INFECTION;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; DRUG DESIGN; EOSINOPHILS; HISTAMINE; HUMANS; HYPERSENSITIVITY; INFLAMMATION; MAST CELLS; PATENTS AS TOPIC; T-LYMPHOCYTES;

EID: 84878641940     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872213X11307020005     Document Type: Review

References (73)

1. rd ed. Saunders (Elsevier): USA 2009.
2. Pawankar R, Canonica GW, Stephen T, Lockey RF. WAO White Book on Allergy: Executive Summary. WAO Publications, Milwaukee, Wisconsin, USA 2011-2012.
3. Naik SR, Wala SM. Inflammation, allergy and asthma, complex origin disease: Mechanism and therapeutic agents. Recent Pat Inflamm Allergy Drug Discov 2013; 7: 62-95.
4. Images of types of allergies. Available at: http://www.medindia.net/patients/patientinfo/images/typeallergies (Accessed on: February 23, 2013).
5. Branum AM, Lulaces SL. Food allergy among US children in prevalence and hospitalization. NCHS Data brief 2008; 10:1-8.
6. Sicherer SH, Sampson HA. Peanut Allergy: Emerging concept and approaches for an apparent epidemic. J Allergy Clin Immunol 2007; 120:491-503.
7. Kay AB. Overview of 'allergy and allergic diseases: With a view to the future. Br Med Bull 2000; 56(4):843-864.
8. Guide for allergy, symptoms, types. Available at: http://www. Webmd.com/allergies/guide/allergy-symptoms-types (Accessed on: February 23, 2013).
9. Mechanism of inflammation. Available at: http://www.information- reliefguide.com/up-content/uploads. (Accessed on: February 22, 2013).
10. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1p generation. Clin Exp Immunol 2007; 47(2):227-235.
11. Incorvaia C, Frati F, Sensi L, Riario-Sforza GG, Marcucci F. Allergic inflammation and the oral mucosa. Recent Pat Inflamm Allergy Drug Discov 2007; 1:35-38.
12. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001; 357:539-545.
13. Munger K. The role of human papillomaviruses in human cancers. Front Biosci 2002; 7:D641-D649.
14. Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, et al. An Association of Cervical Inflammation with High-Grade Cervical Neoplasia in Women Infected with Oncogenic Human Papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001; 10:1021-1027.
15. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002; 55:721-728.
16. rd ed. New York, McGraw-Hill 2005.
17. Kneilling M, Rocken M. Mast cell: Novel clinical perspectives from recent insights. Exp Dermatol 2009; 18:488-496.
18. Mechanism of allergic and inflammatory response. Available at: http://www.ScienceDirect.com. (Accessed on: February 22, 2013)
19. Gordon S. Alternative activation of macrophage. Nat Rev Immunol 2003; 3:23-35.
20. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of new cytokine that induce IFNy production by T-cell. Science 1995; 378:88-91.
21. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cell: Negitiveas wellas positive, regulators of immunity. Nat Rav immu-nol 2008; 8:478-486.
22. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5(12):953-964.
23. Brito FA, Lima LA, Ramos MF, Nakamura MJ, Cavalher-Machado SC, Siani AC, et al. Pharmacological study of anti-allergic activity of Syzygium cumini (L.) Skeels. Braz J Med Biol Res 2007; 40:105-115.
24. Tewtrakul S, Itharat A. Anti-allergic substances from the rhizomes of Dioscorea membranacea. Bioorg Med Chem 2006; 14:8707-8711.
25. Metz M, Maurer M. Mast cell key effector cells in immune responses. Trends Immunol 2007; 28:234-241.
26. Nagai H, Teramachi H, Tuchiya T. Recent Advances in the Development of Anti-allergic Drugs Allergology International 2006;55:35-42
27. Adel-Patient K, Ah-Leung S, Creminon C. Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization. Clin Exp Allergy 2005; 35:539-546.
28. Blaiss MS, National Institute of Health. Management of asthma during pregnancy. Allergy Asthma Proc 2004; 25:375-379.
29. Gibbons D. An audit of the management of acute asthma in accident and emergency. Nurs Times 2005; 101:55-58.
30. Hu W, Kemp A. Managing childhood food allergies and anaphylaxis. Aust Fam Physician 2005; 34:35-38.
31. Information on anti-allergic drugs. Available at: http:// www.drugoffice.gov.hk/eps/root/en/counsumer/news_information/ dm_08.html#a. (Accessed on: February 22, 2013).
32. Yuva B, Laïd B, Hasan A, Bakhotmah BA, Abdellah F, Hammoudi SM, et al. Molecular mechanism underlying anti-inflammatory and anti-allergic activities of phytochemicals: An Update. Molecules 2013; 18:322-353.
33. Information on anti-allergic and anti-inflammatory drug. Available at: www.molecular-networks.com. (Accessed on: February 22, 2013).
34. Information on anti-allergic and anti-inflammatory drug. Available at: www.en.wikipedia.org/wiki/. (Accessed on: February 22, 2013).
35. Information on anti-allergic and anti-inflammatory drug. Available at: www.chemicalize.org (Accessed on: February 22, 2013).
36. Information on anti-allergic and anti-inflammatory drug. Available at: www.biomedcentral.com. (Accessed on: February 22, 2013).
37. David EL, López Q. New methods of prevention and treatment of allergic diseases. Recent Pat Inflamm Allergy Drug Discov 2012; 6:46-64.
38. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 2001; 109:69-75.
39. Jachak SM, Saklani A. Challenges and opportunities in drug discovery from plants. Curr Sci 2007; 92: 1251-1257.
40. Natural anti-inflammatory drugs. Available at:www.naturalnews. com/inflammation.htm. (Accessed on: February 23, 2013).
41. Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy 2000; 30:501-508.
42. Wu SJ, Ng LT, Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells. Biol Pharm Bull 2007; 30:59-62.
43. Riccio P, Rossano R, Liuzzi GM. May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. Autoimmune Dis 2011.
44. Xie L, Li XK, Takahara S. Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immunopharmacol 2011; 11:323-330.
45. Romagnani S. The role of lymphocyte in allergic disease. J Allergy Clin Immunol 2000; 105:399-402.
46. Sano T, Nakamura Y, Matsunaga, Takahashi T, Azuma M, Okano Y, et al. FK 506 and cyclosporine A inhibit granulo-cyte/macrophage colony stimulating factor production by mononu-clear cell in asthma. Eur Respir J 1995; 8(9):1473-1478.
47. Soderstrom L, Kober A, Ahlstedt S, de Groot H, Lange CE, Pagan-elli R, et al. A further evaluation of the clinical use of specific IgE Antibody testing in allergic disease. Allergy 2003; 58:921-928.
48. Takizawa H. Novel strategies for the treatment of asthma. Recent Pat Inflamm Allergy Drug Discov 2007;1:13-19.
49. Ikarashi N, Sato W, Toda T, Ishii M, Ochi IW, Sugiyama K. Inhibitory effect of polyphenol-rich fraction from the bark of Acacia mearnsii on itching associated with allergic dermatitis. Evid Based Complement. Alternat Med 2012; 1-9.
50. Cheong H, Ryu SY, Oak MH, Cheon SH, Yoo GS, Kim KM. Studies of structure activity relationship of flavonoids for the antiallergic actions. Arch Pharm Res 1998; 21:478-480.
51. Fernandez J, Reyes R, Ponce H, Oropeza M, Vancalsteren MR, Jankowski C, et al. Isoquercitrin from Argemone platyceras inhibits carbachol and leukotriene D4-induced contraction in guinea-pig airways. Eur J Pharmacol 2005; 522:108-115.
52. Kim HP, Mani I, Iversen L, Ziboh VA. Effects of naturally occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. Prostaglandins Leukot Essent Fatty Acids 1998; 58:17-24.
53. Fewtrell CM, Gomperts BD. Effect of flavone inhibitors on transport ATPases on histamine secretion from rat mast cells. Nature 1977; 265:635-636.
54. Middleton EJ, Drzewiecki G, Krishnarao D. Quercetin: An inhibitor of antigen-induced human basophil histamine release. J Immunol 1981; 127:546-550.
55. Yano S, Tachibana H, Yamada K. Flavones suppress the expression of the high-affinity IgE receptor Fc epsilon RI in human baso-philic KU812 cells. J Agric Food Chem 2005; 53:1812-1817.
56. Otsuka, Hirai Y, Nagao T, Yamasaki K. Antiinflammatory activity of benzoxazinoids from roots of Coix lachryma-jobi var. ma-yuen. J Nat Prod 1988; 51:74-79.
57. Daikonya A, Katsuki S., Wu JB, Kitanaka S. Anti-allergic agents from natural sources (41): Anti-allergic activity of new phloroglu-cinol derivatives from Mallotus philippensis (Euphorbiaceae). Chem Pharm Bull 2002; 50:1566-1659.
58. Kim MJ, Choung SY. Mixture of polyphenols and anthocyanins from Vaccinium uliginosum L. alleviates DNCB-induced atopic dermatitis in NC/Nga mice. Evid. Based Complement Alternat Med 2012; 1-15.
59. Kawai M, Hirano T, Higa S, Arimitsu J, Maruta M, Kuwahara Y, et al. Flavonoids and related compounds as anti-allergic substances. Allergol Int 2007; 56:113-123.
60. Hirano T, Arimitsu J, Higa S, Naka T, Ogata A, Shima Y, et al. Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophils. Int Arch Allergy Immunol 2006; 140:150-156.
61. Lee, J.C.-L., Adams, J.L., Gallagher, T.F., Green, D. W., Heys, J.R., McDonnell, P.C., McNulty, D.E., Strickler, J. E., Young, P.R. Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins. US5871934 (1999).
62. Rovee, D.T., Marvel, John R., Mezick, J.A. Topical antiinflammatory drug therapy. US4282216 (1981).
63. Yanni, J.M. Ophthalmic anti-allergy compositions suitable for use with contact lenses. EP1250133 (2005). & US6375973 (2002).
64. Braiman-Wiksman, L., Tennenbaum, T., Sagiv, Y., Gartsbein, M., Brener, E., Ben-Hamo, M., Hammer, L. Method for treatment of inflammatory disease and disorder. US8349793 (2013).
65. Chiara M., Raffaella G. Optimised formulation of tobramycin for aerosolization. US8168598 (2012).
66. Gonsalves, A.R., Manuel, A., Jose, D.B., Serra, C.A., Vieira, F.S., Catarina, A., Rui, D.A., Gonsalves, D.C., Maria, A., Figueras, R., Rita, A Process to produce a diclofenac cyclodextrin conjugate. EP2422818 (2012) & EP2422818 (2013).
67. Matteo, D., Giovanni, G. New medicines for topical use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity. US20120121572 (2012).
68. Hayakawa, E., Nakakura, M., Robertson, S.M., Yanni, J.M. Topical ophthalmic formulations for treating allergic eye disease. US5641805 (1997).
69. Wegmann M, Hauber HP. Experimental approaches toward allergic asthma therapy-murine asthma models. Recent Pat Inflamm Allergy Drug Discov 2010; 4:37-53.
70. Alonso-Alija, C, Michels, M., Schirok, H., Schlemer, K.-H., Bell, J., Fitzgerald, M., Dodd, S., Gill, A. Monocyclic aroylpyridi-nones as antiinflammatory agents. US20060046999 (2006).
71. Abbot, P., Bonner, R.V., Brough, S., Chohan, K., McInally, T., Thom, S., Isobe, Y., Nakamura, K., Tojo, S. Purine derivatives for the treatment of viral or allergic diseases and cancers. US20090082332 (2009).
72. Miyamoto, K., Yasuda, Y., Yoshioka, K. Hyaluronic acid derivative and drug containing the same. US2011083991 (2011).
73. King-Underwood, J., Itoa, K., Murray, J.P., Hardy, G., Brookfield, F.A., Brown, C.J. Quinazolin-4 (3H) -one derivatives used as pi3 kinase inhibitors. WO2012052753 (2012).